39052-12-5

Usage

Chemical Properties

Pink Solid

InChI:InChI=1/C10H15NO2/c1-3-12-9-6-5-8(11)7-10(9)13-4-2/h5-7H,3-4,11H2,1-2H3

Upstream product

• 135325-75-6 N-(3-ethoxy-4-hydroxyphenyl)acetamide 
• 55483-70-0 3-ethoxy-4-hydroxyaniline 
• 94-71-3 2-Ethoxyphenol 
• 84702-04-5 3,4-diethoxyacetanilide 
• 4992-63-6 4-Nitro-1,2-diethoxybenzene 

Downstream Products

• 78414-53-6 2,3-Dibromo-N-(3,4-diethoxy-phenyl)-propionamide 
• 1020958-65-9 (3,4-Diethoxy-phenylamino)-acetic acid ethyl ester 
• 499779-04-3 N-(2-carboxyethyl)-N-(3,4-diethoxyphenyl)-β-alanine 
• 1698-92-6 6,7-diethoxy-3-ethoxycarbonyl-4(1H)-quinolone 
• 23375-03-3 N-(3,4-Diethoxy-phenyl)-C,C,C-trifluoro-methanesulfonamide 
• 1180134-25-1 (3,4-Diethoxy-phenyl)-[7-(4-methanesulfonyl-phenyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]-amine 
• 867069-41-8 9-(3,5-dimethoxyphenyl)-6,7-diethoxy-4,9-dihydrofuro[3,4-b]quinolin-1(3H)-one 
• 508212-94-0 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-diethoxyphenyl)urea 
• 92246-27-0 6,7-diethoxy-2-methyl-quinolin-4-ol 

Relevant academic research and scientific papers

Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof

The invention concerns novel benzodiazepine derivatives and their uses in the field of therapeutics particularly for treating pathologies involving the activity of a cyclic nucleotide phosphodiesterase. It also concerns methods for preparing them and novel synthesis intermediates. The inventive compounds more particularly correspond to general formula (I):

BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF

Novel benzene derivatives represented by the formula (I) : wherein R1, R4 and R6 each independently represents a hydrogen atom, a halogen atom or a hydrocarbon group, R2 represents a hydrocarbon group or a heterocyclic group, R3 represents a hydrocarbon group, NR7'R7 or OR8 (wherein R7' represents a hydrogen atom or a hydrocarbon group, R7 represents a non-aromatic group, or R7' and R7 may form a ring with the adjacent nitrogen atom, and R8 represents a hydrocarbon group or a heterocyclic group), R5 represents a hydrocarbon group or a heterocyclic group (except for a quinolyl group), R5' represents a hydrogen atom, or a hydrocarbon group, or R5 and R5' may form a ring with the adjacent nitrogen atom, and R5" represents a hydrogen atom or a hydrocarbon group, which have vanilloid receptor agonist activity and are useful as a drug such as an analgesic and an agent for preventing and/or treating urinary frequency and/or urinary incontinence.